Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 3,840.00
-20.00 (-0.52%)
Aug 12, 2026, 12:09 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 50.36 billion as of August 11, 2026. Its market cap has decreased by -53.90% in one year.
Market Cap
50.36B
Enterprise Value
31.51B
Revenue
475.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,840.00
ChartMarket Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 50.36B, a decrease of -52.60%. That is a compound annual growth rate of -36.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 50.36B | -56.30% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 96.98B |
| MedPacto | 94.94B |
| iNtRON Biotechnology | 80.78B |
| Prestige BioPharma | 79.33B |
| CG Invites | 76.43B |
| Amicogen | 72.14B |
| ENCell | 68.05B |
| ORIENT BIO | 63.14B |